Prohibition Partners
Home / Cannabis Markets / Greece
The Acropolis and Parthenon in Athens at nightGgia · CC BY-SA 3.0
Greece flag

Is cannabis legal in Greece?

Medical cannabis is legal in Greece and adult-use is illegal. Below: a free market overview, with the full sizing, regulation and trade data available from PP.

Medical: LegalAdult-use: Illegal
Compare withPolandDenmarkItaly

Market size

Medical cannabis sales and registered patients in Greece, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Greece data pack.

Medical sales, EUR

€27.4m2025€40m2026€49.2m2027202820292030
Metric202520262027202820292030
Medical sales€27.4m€40m€49.2m
Patients22,11732,32039,697

Forecasts to 2030 — sales, patients and the full Greece series — are in the Greece data pack, or scoped to your question in a bespoke brief.

See the data pack Request a brief

Source: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)

Path to legalisation

Key regulatory milestones

How Greece’s framework got here, and what moves next.

  1. 2017Medical

    Medical cannabis legalised

    Greece reschedules cannabis from Schedule A to D following a campaign led by the patient advocacy group MAMAKA.

  2. 2018Medical

    Cultivation legalised

    Law 4523/2018 legalises medical cannabis cultivation and processing, positioning Greece as a production hub.

  3. 2021Medical

    Import ban prioritises domestic supply

    Article 71 of Law 4864/2021 bans medical cannabis imports, tying the market's fortunes to domestic cultivation.

  4. Feb 2024Medical

    First products reach patients

    The first medical cannabis products become available in Greece on 19 February 2024 — seven years after legalisation.

  5. 2027MedicalOutlook

    Market build-out from a late start

    Sales growth from the February 2024 launch is tracked against PP's forecast in Market Intelligence.

Recently in Greece

From International Cannabis Weekly, our free global briefing.

Latest issue №467
  1. Greece appears to be considering a ban on the sale of hemp flower

    Newsweed · 450 · 22 May 2026 · Regulation

  2. Greece planning hemp flower ban despite warnings it could breach EU law

    Business of Cannabis · 449 · 15 May 2026 · Regulation

  3. Hellenic Dynamics completes Phase 1 facility and pursues additional funding

    356 · 5 Jul 2024 · Business & Investment

  4. Tikun Olam Europe develops finished medical cannabis products in Greece

    353 · 14 Jun 2024 · Medical

  5. Tikun Olam Europe leads change in Greece's medical cannabis market

    346 · 26 Apr 2024 · Medical

  6. Greek Health Minister to speak at Cannabis Europa in London

    344 · 12 Apr 2024 · Events & Industry

Medical cannabis — overview

The first medical cannabis products were made available in Greece on 19 February 2024, which has brought forth a much-anticipated turning point for the growth of the country’s medical cannabis market, as well as providing relief for many patients and advocates. Greece’s estimated medical market size for 2025 is over €13 million.

Although Greece was one of the first countries to legalise medical cannabis in Europe, it took almost seven years for patients to receive medical cannabis treatment. The prolonged delay was due to political changes and a long process in establishing regulatory frameworks for medical cannabis prescription and dispensation, cultivation and production, and the product approval process.

Today, the market is driven by Tikun Olam, which has established itself as the first medical cannabis producer in Greece and has the only products approved on the market. The company currently holds three different flower strains on the market and plans to expand its flower portfolio and introduce its extract products.

Medical cannabis imports remain banned in Greece, however, Tikun Olam exported its first medical cannabis products to Switzerland in November 2024, with the company aiming to supply other markets. In Q1 2025, Greece exported 49 kilograms of medical cannabis to Germany. Additionally, Greece is ramping up its domestic production as more companies are receiving licences to operate, with Curity Pharma receiving its operational cultivation licence in March 2025.

In the full Greece market data

  • Regulations
  • Patient Access
  • Products & Prices

Sizing, forecasts, pricing, trade flows and licensed operators — verified by PP’s analysts. Available as a data pack.